Literature DB >> 15577289

Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study.

G David Batty1, Martin J Shipley, Michael Marmot, George Davey Smith.   

Abstract

OBJECTIVE: While several studies have reported on the relation of diabetes status with pancreatic cancer risk, the predictive value of this disorder for other malignancies is unclear.
METHODS: The Whitehall study, a 25 year follow-up for mortality experience of 18,006 men with data on post-challenge blood glucose and self-reported diabetes, allowed us to address these issues.
RESULTS: There were 2158 cancer deaths at follow-up. Of the 15 cancer outcomes, diabetes status was positively associated with mortality from carcinoma of the pancreas and liver, while the relationship with lung cancer was inverse, after controlling for a range of potential covariates and mediators which included obesity and socioeconomic position. After excluding deaths occurring in the first 10 years of follow-up to examine the effect of reverse causality, the magnitude of the relationships for carcinoma of the pancreas and lung was little altered, while for liver cancer it was markedly attenuated.
CONCLUSIONS: In the present study, diabetes status was related to pancreatic, liver, and lung cancer risk. Cohorts with serially collected data on blood glucose and covariates are required to further examine this area.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577289     DOI: 10.1007/s10552-004-1050-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  45 in total

Review 1.  Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Authors:  Ying Jiang; Qiwen Ben; Hong Shen; Weiqi Lu; Yong Zhang; Jun Zhu
Journal:  Eur J Epidemiol       Date:  2011-09-22       Impact factor: 8.082

2.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

3.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

4.  Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Authors:  Todd MacKenzie; Michael S Zens; Assiamira Ferrara; Alan Schned; Margaret R Karagas
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

5.  Risk of cancer in a large cohort of U.S. veterans with diabetes.

Authors:  Elizabeth A Atchison; Gloria Gridley; J Daniel Carreon; Michael F Leitzmann; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

6.  Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.

Authors:  Rachael Z Stolzenberg-Solomon; Stephanie Weinstein; Michael Pollak; Yuzhen Tao; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2008-09-18       Impact factor: 4.897

7.  Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.

Authors:  Wambui G Gathirua-Mwangi; Patrick O Monahan; Mwangi J Murage; Jianjun Zhang
Journal:  Cancer Causes Control       Date:  2017-01-17       Impact factor: 2.506

8.  Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study.

Authors:  Noel T Mueller; Andrew Odegaard; Kristin Anderson; Jian-Min Yuan; Myron Gross; Woon-Puay Koh; Mark A Pereira
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

Review 9.  Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis.

Authors:  Jae Moon Yoon; Ki Young Son; Chun Sick Eom; Daniel Durrance; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 10.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.